NEW YORK (GenomeWeb News) – Pharsight has signed up Inforsense to distribute its products in China through its subsidiary in Shanghai.
Under the agreement, Inforsense will market Pharsight’s software, which is used in pharmacokinetic and pharmacodynamic analysis, reporting, archiving, and data visualization. Inforsense will distribute the software in the Chinese pharmaceutical and biotech research and development market, and conduct sales and marketing, end-user training, and maintenance and support services.
The companies also have agreed to partner to develop translational research solutions for drug developers, and they may collaborate to use biomarkers in clinical PK/PD modeling.
"Bringing together our capabilities in genotypic and other molecular analysis with Pharsight's PK/PD tools and expertise is a major step towards making the goal of translational research a reality,” Inforsense Chief Scientific Officer Jonathan Sheldon said in a statement.